Drug intelligence / Profile preview

Alcofix

Development stage: Unknown
Lead developer: Alniche Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

**Alcofix** is an oral fixed-dose nutritional supplement marketed by Alniche Life Sciences. The tablet contains thiamine, pyridoxine, folic acid, magnesium, zinc, selenium, and copper, intended to replenish vitamin and mineral deficiencies and provide nutritional support in people with alcohol-associated nutritional deficiency, including those with alcoholic liver disease or alcohol withdrawal. The manufacturer describes the product as a dietary/nutritional supplement rather than a target-specific pharmacologic therapy. ([alniche.com](https://www.alniche.com/product/alcofix/))

Brand names: Alcofix

Beyond the preview

Go deeper on Alcofix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcofix.

Explore the full profile